Cardinal Health Reports Q4 Revenue of $60.2 Billion, Raises FY2026 Guidance
ByAinvest
Tuesday, Aug 12, 2025 3:43 pm ET1min read
CAH--
Cardinal Health's CEO, Jason Hollar, highlighted the company's operational strength, stating, "Fiscal 2025 was a transformative year for Cardinal Health, and we closed the year with momentum, delivering strong fourth quarter results" [1].
The company also announced that it has raised its FY2026 non-GAAP EPS guidance to $9.30-$9.50, a 13-15% increase from the previous guidance of $9.10-$9.30. This increase reflects a benefit to net earnings from classifying the shares held by physicians and management of The Specialty Alliance as a liability and increased contributions from the Pharmaceutical and Specialty Solutions segment and the growth businesses reported in Other [1].
Additionally, Cardinal Health plans to repurchase $750 million worth of shares and expects to spend approximately $600 million on capital expenditures during FY2026. The company also expects non-GAAP adjusted free cash flow to be between $2.75 billion and $3.25 billion for the year [1].
References:
[1] https://newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results-and-Raises-Fiscal-Year-2026-Guidance
Cardinal Health reported Q4 non-GAAP operating earnings of $719 million, a 19% increase, and non-GAAP EPS of $2.08. FY2025 revenue was $222.6 billion, a 2% decrease, but non-GAAP operating earnings rose 15% to $2.8 billion. The company raised FY2026 non-GAAP EPS guidance to $9.30-$9.50, a 13-15% increase, and plans to repurchase $750 million worth of shares.
Cardinal Health (NYSE: CAH) reported its fourth quarter (Q4) and fiscal year 2025 (FY25) results, showing a relatively flat revenue of $60.2 billion for the quarter and a 2% decrease in FY25 revenue to $222.6 billion compared to the previous year. Despite the revenue changes, the company's non-GAAP operating earnings increased significantly. Q4 non-GAAP operating earnings were $719 million, a 19% increase, while non-GAAP EPS was $2.08, a 13% increase. For the full year, non-GAAP operating earnings rose 15% to $2.8 billion, with non-GAAP EPS increasing 9% to $8.24 [1].Cardinal Health's CEO, Jason Hollar, highlighted the company's operational strength, stating, "Fiscal 2025 was a transformative year for Cardinal Health, and we closed the year with momentum, delivering strong fourth quarter results" [1].
The company also announced that it has raised its FY2026 non-GAAP EPS guidance to $9.30-$9.50, a 13-15% increase from the previous guidance of $9.10-$9.30. This increase reflects a benefit to net earnings from classifying the shares held by physicians and management of The Specialty Alliance as a liability and increased contributions from the Pharmaceutical and Specialty Solutions segment and the growth businesses reported in Other [1].
Additionally, Cardinal Health plans to repurchase $750 million worth of shares and expects to spend approximately $600 million on capital expenditures during FY2026. The company also expects non-GAAP adjusted free cash flow to be between $2.75 billion and $3.25 billion for the year [1].
References:
[1] https://newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results-and-Raises-Fiscal-Year-2026-Guidance

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet